Cargando…

Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation

BACKGROUND: TNF-α-stimulated gene 6 (TSG-6) protein, a TNF-α-responsive hyaladherin, possesses enzymatic activity that can catalyze covalent crosslinks of the polysaccharide hyaluronic acid (HA) to another protein to form heavy chain-hyaluronic acid (HC-HA) complexes in pathological conditions such...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasanello, Diana C., Su, Jin, Deng, Siyu, Yin, Rose, Colville, Marshall J., Berenson, Joshua M., Kelly, Carolyn M., Freer, Heather, Rollins, Alicia, Wagner, Bettina, Rivas, Felipe, Hall, Adam R., Rahbar, Elaheh, DeAngelis, Paul L., Paszek, Matthew J., Reesink, Heidi L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377964/
https://www.ncbi.nlm.nih.gov/pubmed/34416923
http://dx.doi.org/10.1186/s13075-021-02588-7
_version_ 1783740746198679552
author Fasanello, Diana C.
Su, Jin
Deng, Siyu
Yin, Rose
Colville, Marshall J.
Berenson, Joshua M.
Kelly, Carolyn M.
Freer, Heather
Rollins, Alicia
Wagner, Bettina
Rivas, Felipe
Hall, Adam R.
Rahbar, Elaheh
DeAngelis, Paul L.
Paszek, Matthew J.
Reesink, Heidi L.
author_facet Fasanello, Diana C.
Su, Jin
Deng, Siyu
Yin, Rose
Colville, Marshall J.
Berenson, Joshua M.
Kelly, Carolyn M.
Freer, Heather
Rollins, Alicia
Wagner, Bettina
Rivas, Felipe
Hall, Adam R.
Rahbar, Elaheh
DeAngelis, Paul L.
Paszek, Matthew J.
Reesink, Heidi L.
author_sort Fasanello, Diana C.
collection PubMed
description BACKGROUND: TNF-α-stimulated gene 6 (TSG-6) protein, a TNF-α-responsive hyaladherin, possesses enzymatic activity that can catalyze covalent crosslinks of the polysaccharide hyaluronic acid (HA) to another protein to form heavy chain-hyaluronic acid (HC-HA) complexes in pathological conditions such as osteoarthritis (OA). Here, we examined HA synthase and inflammatory gene expression; synovial fluid HA, TNF-α, and viscosity; and TSG-6-mediated HC-HA complex formation in an equine OA model. The objectives of this study were to (1) evaluate the TNF-α-TSG-6-HC-HA signaling pathway across multiple joint tissues, including synovial membrane, cartilage, and synovial fluid, and (2) determine the impact of OA on synovial fluid composition and biophysical properties. METHODS: HA and inflammatory cytokine concentrations (TNF-α, IL-1β, CCL2, 3, 5, and 11) were analyzed in synovial fluid from 63 OA and 25 control joints, and HA synthase (HAS1-3), TSG-6, and hyaluronan-degrading enzyme (HYAL2, HEXA) gene expression was measured in synovial membrane and cartilage. HA molecular weight (MW) distributions were determined using agarose gel electrophoresis and solid-state nanopore measurements, and HC-HA complex formation was detected via immunoblotting and immunofluorescence. SEC-MALS was used to evaluate TSG-6-mediated HA crosslinking, and synovial fluid and HA solution viscosities were analyzed using multiple particle-tracking microrheology and microfluidic measurements, respectively. RESULTS: TNF-α concentrations were greater in OA synovial fluid, and TSG6 expression was upregulated in OA synovial membrane and cartilage. TSG-6-mediated HC-HA complex formation was greater in OA synovial fluid and tissues than controls, and HC-HA was localized to both synovial membrane and superficial zone chondrocytes in OA joints. SEC-MALS demonstrated macromolecular aggregation of low MW HA in the presence of TSG-6 and inter-α-inhibitor with concurrent increases in viscosity. CONCLUSIONS: Synovial fluid TNF-α concentrations, synovial membrane and cartilage TSG6 gene expression, and HC-HA complex formation were increased in equine OA. Despite the ability of TSG-6 to induce macromolecular aggregation of low MW HA with resultant increases in the viscosity of low MW HA solutions in vitro, HA concentration was the primary determinant of synovial fluid viscosity rather than HA MW or HC-HA crosslinking. The TNF-α-TSG-6-HC-HA pathway may represent a potential therapeutic target in OA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02588-7.
format Online
Article
Text
id pubmed-8377964
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83779642021-08-23 Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation Fasanello, Diana C. Su, Jin Deng, Siyu Yin, Rose Colville, Marshall J. Berenson, Joshua M. Kelly, Carolyn M. Freer, Heather Rollins, Alicia Wagner, Bettina Rivas, Felipe Hall, Adam R. Rahbar, Elaheh DeAngelis, Paul L. Paszek, Matthew J. Reesink, Heidi L. Arthritis Res Ther Research Article BACKGROUND: TNF-α-stimulated gene 6 (TSG-6) protein, a TNF-α-responsive hyaladherin, possesses enzymatic activity that can catalyze covalent crosslinks of the polysaccharide hyaluronic acid (HA) to another protein to form heavy chain-hyaluronic acid (HC-HA) complexes in pathological conditions such as osteoarthritis (OA). Here, we examined HA synthase and inflammatory gene expression; synovial fluid HA, TNF-α, and viscosity; and TSG-6-mediated HC-HA complex formation in an equine OA model. The objectives of this study were to (1) evaluate the TNF-α-TSG-6-HC-HA signaling pathway across multiple joint tissues, including synovial membrane, cartilage, and synovial fluid, and (2) determine the impact of OA on synovial fluid composition and biophysical properties. METHODS: HA and inflammatory cytokine concentrations (TNF-α, IL-1β, CCL2, 3, 5, and 11) were analyzed in synovial fluid from 63 OA and 25 control joints, and HA synthase (HAS1-3), TSG-6, and hyaluronan-degrading enzyme (HYAL2, HEXA) gene expression was measured in synovial membrane and cartilage. HA molecular weight (MW) distributions were determined using agarose gel electrophoresis and solid-state nanopore measurements, and HC-HA complex formation was detected via immunoblotting and immunofluorescence. SEC-MALS was used to evaluate TSG-6-mediated HA crosslinking, and synovial fluid and HA solution viscosities were analyzed using multiple particle-tracking microrheology and microfluidic measurements, respectively. RESULTS: TNF-α concentrations were greater in OA synovial fluid, and TSG6 expression was upregulated in OA synovial membrane and cartilage. TSG-6-mediated HC-HA complex formation was greater in OA synovial fluid and tissues than controls, and HC-HA was localized to both synovial membrane and superficial zone chondrocytes in OA joints. SEC-MALS demonstrated macromolecular aggregation of low MW HA in the presence of TSG-6 and inter-α-inhibitor with concurrent increases in viscosity. CONCLUSIONS: Synovial fluid TNF-α concentrations, synovial membrane and cartilage TSG6 gene expression, and HC-HA complex formation were increased in equine OA. Despite the ability of TSG-6 to induce macromolecular aggregation of low MW HA with resultant increases in the viscosity of low MW HA solutions in vitro, HA concentration was the primary determinant of synovial fluid viscosity rather than HA MW or HC-HA crosslinking. The TNF-α-TSG-6-HC-HA pathway may represent a potential therapeutic target in OA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02588-7. BioMed Central 2021-08-20 2021 /pmc/articles/PMC8377964/ /pubmed/34416923 http://dx.doi.org/10.1186/s13075-021-02588-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Fasanello, Diana C.
Su, Jin
Deng, Siyu
Yin, Rose
Colville, Marshall J.
Berenson, Joshua M.
Kelly, Carolyn M.
Freer, Heather
Rollins, Alicia
Wagner, Bettina
Rivas, Felipe
Hall, Adam R.
Rahbar, Elaheh
DeAngelis, Paul L.
Paszek, Matthew J.
Reesink, Heidi L.
Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation
title Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation
title_full Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation
title_fullStr Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation
title_full_unstemmed Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation
title_short Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation
title_sort hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: tnf-α-tsg-6-mediated hc-ha formation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377964/
https://www.ncbi.nlm.nih.gov/pubmed/34416923
http://dx.doi.org/10.1186/s13075-021-02588-7
work_keys_str_mv AT fasanellodianac hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT sujin hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT dengsiyu hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT yinrose hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT colvillemarshallj hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT berensonjoshuam hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT kellycarolynm hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT freerheather hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT rollinsalicia hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT wagnerbettina hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT rivasfelipe hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT halladamr hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT rahbarelaheh hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT deangelispaull hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT paszekmatthewj hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation
AT reesinkheidil hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation